Showing 5,781 - 5,800 results of 9,864 for search '"drug"', query time: 0.06s Refine Results
  1. 5781
  2. 5782

    Efficacy and Tolerability of a Combined Moxifloxacin/Dexamethasone Formulation for Topical Prophylaxis in Phacoemulsification: An Open-Label Single-Arm Clinical Trial by Cesar Ramon G. Espiritu, Mary Ellen A. Sy, Tommee Lynne G. Tayengco

    Published 2011-01-01
    “…At the end of the study period, 8.3% were given fluorometholone for 1 week for AC reaction grade >0. No drug-related adverse event was reported. Conclusion. …”
    Get full text
    Article
  3. 5783
  4. 5784

    The Bacterial Profile and Antimicrobial Susceptibility Patterns of Urinary Tract Infection Patients at Pawe General Hospital, Northwest Ethiopia by Abayeneh Girma, Aleka Aemiro

    Published 2022-01-01
    “…Periodic monitoring of etiology and drug susceptibility is highly recommended, along with health education on the transmission and causes of urinary tract infection.…”
    Get full text
    Article
  5. 5785
  6. 5786

    Fluorescence Diagnostics of Colon Malignant and Premalignant Lesions Using 5-Aminolevulinic Acid by Elena V. Filonenko, Andrey D. Kaprin, Antonina A. Raszhivina, Antonina N. Urlova, Andrey M. Nechipai

    Published 2014-01-01
    “…For the study we used drug Alasens based on 5-ALA. Fluorescence colonoscopy with Alasens was made using the visual assessment of fluorescence images in combination with local fluorescence spectroscopy. …”
    Get full text
    Article
  7. 5787

    Therapeutic Targeting of MOAP-1 in Cancer: A Systematic Review of Current Approaches and Future Directions by Xinwei Koong, Keyun Look, Amar Daud Iskandar Abdullah, Kuan Onn Tan, Vasudevan Mani, Hooi-Leng Ser, Khang Wen Goh, Ali Saleh Alkhoshaiban, Long Chiau Ming

    Published 2023-12-01
    “…In addition, apoptosis in breast cancer cells was induced by α-mangostin, a potential therapeutic drug targeting MOAP-1 and BCL-XL interaction. Studies showed MOAP-1's importance in NSCLC, with its upregulation in the cancer cells as a potential treatment. …”
    Get full text
    Article
  8. 5788

    Determination of Arctiin and Arctigenin Contents in Arctium Tomentosum Mill. by HPLC Method by Xiaoying Zhou, Haoke Zhang, Liang Ge, Haiyan Gong, Shuge Tian

    Published 2011-01-01
    “…Therefore, the developed HPLC method can be applied to both in vitro studies of arctiin and arctigenin formulations as well as drug estimation in biological samples.…”
    Get full text
    Article
  9. 5789

    Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer by Ying Huang, Xihan Li, Tong Zhu, Jian Lin, Gaojian Tao

    Published 2015-01-01
    “…Objective. Although intrathecal drug infusion has been commonly adopted for terminal cancer pain relief, its adverse effects have made many clinicians reluctant to employ it for intractable cancer pain. …”
    Get full text
    Article
  10. 5790

    Antibiofilm Activity of Curcumin and Piperine and Their Synergistic Effects with Antifungals against Candida albicans Clinical Isolates by Ulrich Joël Tsopmene, Christian Ramsès Tokam Kuaté, Prudence Ngalula Kayoka-Kabongo, Borel Ndezo Bisso, Anisel Metopa, Clautilde Teugwa Mofor, Jean Paul Dzoyem

    Published 2024-01-01
    “…The combination of curcumin and piperine with antifungals has shown synergistic effects against multiresistant clinical isolates of Candida albicans representing an alternative drug research for the treatment of clinical candidiasis.…”
    Get full text
    Article
  11. 5791

    Antidiabetic Potential of Senna siamea: α-Glucosidase Inhibition, Postprandial Blood Glucose Reduction, Toxicity Evaluation, and Molecular Docking by Suthinee Sangkanu, Armad Heemman, Sathianpong Phoopha, Thanet Pitakbut, Wandee Udomuksorn, Sukanya Dej-adisai

    Published 2025-01-01
    “…This study offers encouraging information on the potential of natural compounds from S. siamea to act as α-glucosidase inhibitors for diabetes treatment through drug development or dietary supplement for hyperglycemia individuals.…”
    Get full text
    Article
  12. 5792

    Prevalence, Determinants, and Antibiotic Resistance Patterns of Urinary Tract Infections in Antenatal Women in an Urban Resettlement Colony and Slum in Delhi, India: A Cross-sectio... by Divya Gupta, Mongjam M. Singh, Saurav Basu, Suneela Garg, CP Baveja, YM Mala

    Published 2025-01-01
    “…The initiation of presumptive antibiotic therapy for UTI cases in pregnant women should be restricted to painful micturition due to high false positivity of other symptoms with Nitrofurantoin being a likely preferred drug for empirical administration due to its low resistance pattern among isolated organisms.…”
    Get full text
    Article
  13. 5793

    Business partnership, women empowerment and support to women living with HIV/AIDS in Kabale, Uganda. by Mwosi, Fabian, Eton, Marus, Aluonzi, Burani, Olupot, Simon Peter, Alia, Richard

    Published 2024
    “…Limitations: This study encountered the challenge of interfacing with the respondents since the information was collected by those in charge of the drug distribution center but not the researchers and this affected in-depth investigations. …”
    Get full text
    Article
  14. 5794
  15. 5795

    Off-the-shelf CAR-NK cells targeting immunogenic cell death marker ERp57 execute robust antitumor activity and have a synergistic effect with ICD inducer oxaliplatin by Jichao Sun, Dinglan Wu, Liuhai Zheng, Huifang Wang, Jihao Zhou, Guangwei Shi, Jingbo Ma, Yuke Jiang, Zhiyu Dong, Jiexuan Li, Yuan-Qiao He, Chengchao Xu, Zhijie Li, Jigang Wang

    Published 2024-07-01
    “…Additionally, the antitumor activity of G6-CAR-NK92 cells is synergistically enhanced by the low-dose ICD-inducible drug OXP.Conclusion Collectively, our findings suggest that ERp57 can be leveraged as a new tumor antigen for CAR-NK targeting, and the resultant CAR-NK cells have the potential to be applied as a broad-spectrum immune cell therapy for various cancers by combining with ICD inducer drugs.…”
    Get full text
    Article
  16. 5796

    Combined Age with Mean Decrease Rates of Total Bilirubin and MELD Score as a Novel and Simple Clinical Predictor on 90-Day Transplant-Free Mortality in Adult Patients with Acute Li... by Di Jin, Kai Kang, Bing-zhu Yan, Jian-nan Zhang, Jun-bo Zheng, Zhi-hui Wang, Di Wu, Yu-jia Tang, Xin-tong Wang, Qi-qi Lai, Yang Cao, Hong-liang Wang, Yang Gao

    Published 2023-01-01
    “…Acute liver failure (ALF), previously known as fulminant hepatic failure, has become a common, rapidly progressive, and life-threatening catastrophic hepatic disease in intensive care unit (ICU) due to the continuous increase in drug abuse, viral infection, metabolic insult, and auto-immune cause. …”
    Get full text
    Article
  17. 5797

    Current AAV-mediated gene therapy in sensorineural hearing loss by Jieyu Qi, Xiaolong Fu, Liyan Zhang, Fangzhi Tan, Nianci Li, Qiuhan Sun, Xiaojie Hu, Zuhong He, Ming Xia, Renjie Chai

    Published 2025-01-01
    “…The number of patients with hearing loss is on the rise due to congenital abnormalities, degenerative changes in old age, and acquired injuries such as virus or ototoxic drug-induced diseases. Hearing loss is a refractory and disabling disease that has serious negative effects on quality of life. …”
    Get full text
    Article
  18. 5798

    Evidence construction of Silibinin capsules against alcoholic liver disease based on a meta-analysis and systematic review by Yan Wang, Yan Wang, Wenmin Yang, Wenmin Yang, Yuan Yang, Yuan Yang, Xingning Liu, Xingning Liu, Lanfen Peng, Lanfen Peng, Qi Huang, Qi Huang, Qi Huang, Kongli Fan, Kongli Fan, Rui Hu, Rui Hu, Jinyu Yi, Jinyu Yi, Xin Zhong, Xin Zhong, Jing Li, Jialing Sun, Xiaozhou Zhou, Xiaozhou Zhou

    Published 2025-02-01
    “…At present, the mechanism of action of this drug for ALD is still unclear, and we expect more experimental studies to prove the clinical value of Silibinin capsules.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/display_record.php?…”
    Get full text
    Article
  19. 5799

    Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime by M. Mathy-Hartert, G. Deby-Dupont, C. Deby, L. Jadoul, A. Vandenberghe, M. Lamy

    Published 1995-01-01
    “…Dose dependent protection was obtained for CAZ concentrations ranging from 10−5 to 10−3 M;this can be attributed to inactivation of HOCl by the drug. This protection is comparable to that obtained with methionine and histidine, both of which are known to neutralize HOCl. …”
    Get full text
    Article
  20. 5800